Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Preferred Shares (2023 - 2025)

INVO Fertility (IVF) has disclosed Preferred Shares for 3 consecutive years, with $8.9 million as the latest value for Q3 2025.

  • Quarterly Preferred Shares rose 47.96% to $8.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Sep 2025, up 47.96% year-over-year, with the annual reading at $30.4 million for FY2024, 406.25% up from the prior year.
  • Preferred Shares for Q3 2025 was $8.9 million at INVO Fertility, down from $10.1 million in the prior quarter.
  • The five-year high for Preferred Shares was $30.4 million in Q4 2024, with the low at $500000.0 in Q1 2024.
  • Average Preferred Shares over 3 years is $11.7 million, with a median of $7.4 million recorded in 2023.
  • Peak annual rise in Preferred Shares hit 5975.0% in 2025, while the deepest fall reached 47.96% in 2025.
  • Over 3 years, Preferred Shares stood at $6.0 million in 2023, then soared by 406.25% to $30.4 million in 2024, then plummeted by 70.77% to $8.9 million in 2025.
  • According to Business Quant data, Preferred Shares over the past three periods came in at $8.9 million, $10.1 million, and $30.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.